Free Trial

Barclays PLC Buys 54,591 Shares of Paragon 28, Inc. (NYSE:FNA)

Paragon 28 logo with Medical background

Barclays PLC raised its holdings in Paragon 28, Inc. (NYSE:FNA - Free Report) by 180.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 84,812 shares of the company's stock after purchasing an additional 54,591 shares during the quarter. Barclays PLC owned 0.10% of Paragon 28 worth $567,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of FNA. First Light Asset Management LLC lifted its position in shares of Paragon 28 by 115.0% during the 2nd quarter. First Light Asset Management LLC now owns 8,174,832 shares of the company's stock worth $55,916,000 after buying an additional 4,371,864 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Paragon 28 by 5,834.0% in the second quarter. Millennium Management LLC now owns 725,489 shares of the company's stock worth $4,962,000 after acquiring an additional 713,263 shares during the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Paragon 28 by 15.4% in the second quarter. Thrivent Financial for Lutherans now owns 1,021,188 shares of the company's stock worth $6,986,000 after acquiring an additional 135,911 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new stake in shares of Paragon 28 in the 2nd quarter valued at approximately $869,000. Finally, Stonepine Capital Management LLC bought a new stake in shares of Paragon 28 during the 3rd quarter valued at approximately $766,000. Institutional investors and hedge funds own 63.57% of the company's stock.

Paragon 28 Trading Up 1.8 %

NYSE FNA traded up $0.19 on Friday, hitting $10.85. The company's stock had a trading volume of 707,932 shares, compared to its average volume of 586,794. The company's 50-day moving average is $10.18 and its 200 day moving average is $8.10. The firm has a market cap of $908.61 million, a PE ratio of -14.67 and a beta of 1.50. Paragon 28, Inc. has a 1-year low of $4.65 and a 1-year high of $14.79. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79.

Paragon 28 (NYSE:FNA - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, beating analysts' consensus estimates of ($0.16) by $0.01. The business had revenue of $62.30 million during the quarter, compared to the consensus estimate of $60.58 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. Paragon 28's quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the business posted ($0.10) earnings per share. As a group, analysts predict that Paragon 28, Inc. will post -0.66 earnings per share for the current fiscal year.

Insider Transactions at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 72,133 shares of the stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $10.16, for a total transaction of $732,871.28. Following the completion of the sale, the insider now owns 10,559,065 shares of the company's stock, valued at approximately $107,280,100.40. This represents a 0.68 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold 252,914 shares of company stock worth $2,585,514 over the last ninety days. 15.32% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on FNA shares. Needham & Company LLC restated a "buy" rating and issued a $13.00 target price on shares of Paragon 28 in a research report on Monday. Canaccord Genuity Group dropped their price target on Paragon 28 from $17.00 to $15.00 and set a "buy" rating for the company in a research note on Wednesday, November 13th. Finally, Stephens upgraded Paragon 28 to a "strong-buy" rating in a research report on Monday, December 2nd. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, Paragon 28 presently has a consensus rating of "Buy" and a consensus price target of $15.60.

Check Out Our Latest Report on Paragon 28

Paragon 28 Profile

(Free Report)

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.

Featured Stories

Institutional Ownership by Quarter for Paragon 28 (NYSE:FNA)

Should You Invest $1,000 in Paragon 28 Right Now?

Before you consider Paragon 28, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paragon 28 wasn't on the list.

While Paragon 28 currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Quantum Computing Stocks to Watch in 2025 (That Aren’t Rigetti)
Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines